Journal of Clinical Virology

Article	Citations
Quantification of human immunodeficiency virus type 2 (HIV-2) viral load in plasma: Comparison of three commercial assays	92
ESCV/PASCV Membership	81
Editorial Board	53
Enrichment of SARS-CoV-2 sequence from nasopharyngeal swabs whilst identifying the nasal microbiome	52
Comparison of sputum specimens and nasopharyngeal swab specimens for diagnosis of acute human metapneumovirus-related lower respiratory tract infections in adults	50
Trends in the detection of viruses causing gastroenteritis over a 10-year period and impact of nonpharmaceutical interventions	49
Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections	46
Epidemiology of hand, foot and mouth disease and genomic surveillance of coxsackievirus A10 circulating in Zhejiang Province, China during 2017 to 2022	43
Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (	35
The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays	34
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization	34
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens	33
Corrigendum to “First international proficiency study on human papillomavirus testing in cervical cancer screening” [J Clin Virol. 2023 Oct;167:105581]	31
Multicenter performance evaluation of the Elecsys HCV Duo immunoassay	31
Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population	30
Recent HIV-1 infection in Israel 2017–2021: Evaluation of geenius and HIV-1/2 combo assays for identifying recent infection detected by Sedia assay and assessment of factors related to recent infectio	28
Detection of La Crosse virus RNA in clinical specimens obtained from children with La Crosse infection	27
Human coronaviruses: Origin, host and receptor	26
Editorial Board	25
Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.	25
Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons	25
Editorial Board	25
Clinical presentation, viral shedding, and neutralizing antibody responses of mpox cases in South Korea: Single center experience	24
Evaluation of a next generation sequencing assay for Hepatitis B antiviral drug resistance on the oxford nanopore system	24
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.	24

A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S.	23
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study	23
Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics	23
Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System	23
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study	22
The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.	22
Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens	21
Optimising nucleic acid recovery from rapid antigen tests for whole genome sequencing of respiratory viruses	21
Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistance	20
Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia	20
The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics package	19
Direct whole-genome sequencing of HIV-1 for clinical drug-resistance analysis and public health surveillance	19
Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study	19
Practical management of positive norovirus results from FilmArray® GI panel	18
Predictors of chronic joint pain after Chikungunya virus infection in the INOVACHIK prospective cohort study	18
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection	18
Non-polio enterovirus aseptic meningitis in infants up to three months of age, the bacterial mask of viral disease: A retrospective cohort study	18
Opt-out HIV screening in adults attending the Emergency Department of a London teaching hospital	18
Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome	18
Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study	17
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settings	17
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis	17
Detection of HIV-1 drug resistance in RNA and proviral DNA genotyping is variable both longitudinally and during repeat testing	17
Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter study	17
Editorial Board	17
Prevalence and epidemiology of enterovirus species in a pediatric oncology patient population	17
Investigation of suspected false positive norovirus results on a syndromic gastrointestinal multiplex molecular panel	17
A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field	16
Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection	16
Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting	16
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures	16
Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test	15
Editorial Board	15
Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to RT-PCR on nasal and oropharyngeal samples	15
Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities	15
Current regulatory landscape for viral point-of-care testing in the United States	15
Parvovirus B19 remains an underestimated pathogen among infections during gestation in Argentina: Insights through the study of symptomatic and asymptomatic pregnant patients and newborns from Córdoba	15
A machine learning model for predicting complete virological response in chronic hepatitis B patients receiving first-line nucleos(t)ide analogues therapy	15
In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing	14
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment	14
Editorial Board	14
Detection of intrathecal antibodies to diagnose enterovirus infections of the central nervous system	14
A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses	13
Clinical evaluation of Xpert HIV Qual XC assay in diverse HIV-1 subtypes circulating in China	13
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study	13
False-positive results in fourth-generation HIV screening tests: Prevalence and associated factors in Sichuan, a high HIV burden province of China	13
The evolving landscape of Norovirus GII genotypes in Asia: A systematic review and meta-analysis	13
Characteristics of hepatitis E viral infections in Hungary	13
Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects	13
DENV-1 genotype V linked to the 2022 dengue epidemic in Southern Brazil	13

Refined fully automated RT-qPCR assay for simultaneous detection of SARS-CoV-2, Influenza A/B, and RSV with target optimization for improved variant resilience	12
The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis	12
Evaluation of urinary hepatitis E virus antigen colloidal gold immunochromatographic assay in clinical diagnosis of hepatitis E virus infection	12
HIV-1 genotypic resistance testing using single molecule real-time sequencing	12
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients	12
Circulating serotypes and genotypes of dengue virus during the 2023 outbreak in Eastern Nepal	12
Editorial Board	12
Arbovirus outbreak in a rural region of the Brazilian Amazon	12
Genotypic testing improves detection of antiviral resistance in human herpes simplex virus	12
Fourth generation HIV rapid diagnostic test: Adequate sensitivity in HIV primary infection settings?	11
Comparison of two new HTLV-I/II screening methods, Abbott Alinity i rHTLV-I/II and Diasorin LIAISON® XL murex recHTLV-I/II, to Abbott architect rHTLVI/II assay	11
Detection and molecular characterisation of tick-borne encephalitis virus in CSF and serum in relation to disease severity	11
A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts	11
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus	11
The Human Papillomavirus (HPV) Laboratory e-Manual: A comprehensive guide for HPV testing and research	11
Clinical characterization of COVID-19 breakthrough infections, Philippines	11
Identifying people with chronic hepatitis B virus who are lost to clinical follow up: A retrospective case finding and re-engagement service improvement exercise	11
Clinical scoring system to predict viable viral shedding in patients with COVID-19	10
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves	10
Impact on hospital length of stay and antimicrobial usage in children diagnosed with viral meningitis by rapid multiplexed PCR assay	10
Heterogeneity of false reactivity profiles of HIV assays while optimizing national HIV testing algorithms: Findings from a multi-country analysis	10
Assessing B19V epidemiology and viremia dynamics in plasma donors: A comprehensive analysis	10
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues	10
Diagnosing congenital cytomegalovirus infections using archived dried blood spots: A 15-year observational study, Portugal	10
COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates)	10
Editorial Board	10
Genotypic shift in rotavirus associated with neonatal outbreaks in Seoul, Korea	10
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series	10
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays	9
Seroprevalence of Respiratory Syncytial Virus in the antenatal population in British Columbia: A cross-sectional study	9
Coinfections and iterative detection of respiratory viruses among 17,689 patients between March 2021 and December 2022 in Southern France	9
Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan	9
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study	9
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis	9
Bacterial colonization and life-threatening respiratory syncytial virus infection in children	9
Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019	9
TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion	9
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study	9
Molecular epidemiology of a Parainfluenza Type 3 virus outbreak: Informing infection control measures on adult hematology wards	9
SpikeID: Rapid and unbiased identification of SARS-CoV-2 variants by spike sequencing	9
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)	9
Arbovirus surveillance in pregnant women in north-central Nigeria, 2019–2022	9
The prognostic potential of fetal platelet count and viral load in prenatal cytomegalovirus infection: A retrospective cohort of 74 cases	9
Zoonotic influenza preparedness: Dutch medical labs efficiently detect animal influenza A viruses - External Quality Assessment, 2023	9
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests	9
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants	9
Use of PCR to exclude HIV-1 infection in high-risk patient populations following discordant serological results	9
Cytomegalovirus urinary excretion in children with congenital and postnatally acquired infection	8
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals	8
More aggressive initiation of antiviral treatment contributes to blocking mother-to-child transmission of HBV DNA & RNA in neonatal umbilical cord blood	8
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination era	8
Clinical and molecular characteristics of the 2022 Enterovirus-D68 outbreak among hospitalized children, Ohio, USA	8
Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values	8
Detection of diverse HIV strains by the m-PIMATM HIV-1/2 detect point-of-care assay	8
Epidemiologic, clinical, and genetic characteristics of influenza C virus infections among outpatients and inpatients in Sendai, Japan from 2006 to 2020	8
Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay	8
Novel fully automated prototype assays for specific detection of phosphorylated and non-phosphorylated Hepatitis B core antigens	8
Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent host	8
Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy	8
Versatile performance edges of HBsAg Next assay in diagnosis and therapeutic monitoring of HBV infection	8
Human papillomavirus incidence and transmission by vaccination status among heterosexual couples	8
Evaluation of dried blood spots for Epstein–Barr virus nucleic acid testing	8
Editorial Board	8
Impact of metformin on HBV replication: No evidence of suppression in vitro	8
Portable Nanopore sequencing solution for next-generation HIV drug resistance testing	8
Development and evaluation of an easy to use real-time reverse-transcription loop-mediated isothermal amplification assay for clinical diagnosis of West Nile virus	7
Editorial Board	7
ESCV/PASCV Membership	7
Deep sequencing analysis of clinical samples from patients with acute infectious conjunctivitis during the COVID-19 delta surge in Madurai, India	7
Coordinated implementation of a conventional PCR assay to detect all Ebola and Marburg virus species in a European laboratory network	7
Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals	7
Shedding of rubella virus in postsymptomatic individuals; viral RNA load is a potential indicator to estimate candidate patients excreting infectious rubella virus	7
ESCV/PASCV Membership	7
Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies	7
Epidemiological and genetic characteristics of norovirus in Hangzhou, China, in the postepidemic era	7
Corrigendum to Focusing on severe infections with the Respiratory Syncytial Virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-Co	7
ESCV/PASCV Membership	7
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study	7
ESCV/PASCV Membership	7
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir	7

Comparative evaluation of four commercial analyzers for the serological screening of hepatitis A, B, C and HIV	7
Evaluation of a custom designed hybridisation assay for whole genome sequencing of human adenoviruses direct from clinical samples	7
Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients	7
False positive congenital cytomegalovirus saliva screening results with an FDA-approved assay at two institutions	6
The diagnostic complexities of human herpesvirus 6 (HHV-6) infections	6
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy	6
Assessment of an automated Cytomegalovirus nucleic acid amplification test using clinical plasma, bronchoalveolar lavage, and tissue specimens	6
Genomic characterization of coxsackievirus A22 from a regional university hospital in the Netherlands	6
Cytomegalovirus detected by qPCR in iris and ciliary body of immunocompetent corneal donors	6
Improving the accuracy of clinical interpretation of serological testing for the diagnosis of acute hepatitis a infection	6
Hunting for mpox (monkeypox) mimickers: Use of the Biofire meningitis/encephalitis panel on lesion swabs to support alternative viral diagnoses	6
Molecular epidemiology of Hepatitis E virus among humans in the Niger Republic, 2017–2023	6
Importance of internal controls to monitor adequate specimen collection: The case of orthopoxvirus real-time PCR	6
Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron	6
Enterovirus meningitis in Mayotte French Comoros Island, March-June 2019	6
Hand, foot, and mouth disease outbreak by Coxsackievirus A6 during COVID-19 pandemic in 2021, São Paulo, Brazil.	6
Impact of public health measures and new introducing variants on Respiratory syncytial virus recrudescence in Taiwan during the COVID-19 pandemic	6
Analytical and clinical evaluation of the cobas Epstein–Barr virus test at a tertiary care cancer hospital	6
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients	6
Standardization and evaluation of an in-house ELISA for the detection of rabies antibody in a tertiary care centre in South India	6
Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea	6
Performance of the Alinity m HR HPV assay on self-collected vaginal samples compared to clinician-collected cervical samples	6
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19	6
Epidemiological and genetic characteristics of respiratory syncytial virus infection in children from Hangzhou after the peak of COVID-19	6
A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR	6
Melting curve analysis reveals false-positive norovirus detection in a molecular syndromic panel	5
Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays	5
Detection of human herpesvirus type 6 DNA in cerebrospinal fluid is rarely clinically significant	5
ESCV/PASCV Membership	5
Evaluation of the ELITechGroup solution for plasma HIV-1 RNA quantification	5
Emergence of Parechovirus-A5 central nervous system infections in children from Kansas City, Missouri, USA	5
Editorial Board	5
Long-term follow-up of a series of 24 congenital CMV-infected babies with false negative amniocentesis	5
Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection	5
ESCV/PASCV Membership	5
Nonlinear interdependence of the results of measuring anti-SARS-CoV-2 IgG levels using Abbott and Euroimmun test systems	5
Gestational age-dependent dynamics of transplacental CMV and VZV IgG transfer: Weekly comparative analysis in preterm and full-term neonates (24–41 weeks)	5
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters – Practical use of viral load for disease control	5
Impact of rhinovirus on hospitalization during the COVID-19 pandemic: A prospective cohort study.	5
Limited utility of Epstein–Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients	5
Management and outcomes of children hospitalised with COVID-19 including incidental and nosocomial infections in Australia 2020–2023: A national surveillance study	5
Performance of a rapid recency assay for detection of early HIV infection	4
Clinical and phylogenetic influenza dynamics for the 2019-20 season in the global influenza hospital surveillance network (GIHSN) – Pilot study	4
Editorial Board	4
Editorial Board	4
Development and evaluation of a novel RT-qPCR assay for detection of Crimean Congo haemorrhagic fever virus using the Genedrive® point-of-care platform	4
Correlation between monkeypox viral load and infectious virus in clinical specimens	4
Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2	4
Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation	4
2025 JCV reviewer recognition list and best reviewer awards	4
Virus-induced onychomadesis: Exploring the role of viral infection in nail shedding	4
Editorial Board	4
A series of diagnostic contamination events from seasonal influenza vaccines	4
Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples	4
Evaluation of a diagnostic metagenomic sequencing assay: Virus detection sensitivity and background nucleic acids in three different sample materials	4
Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients	4
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain	4
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients	4
FDA trial regulation of laboratory developed tests (LDTs): An academic medical center's experience with Mpox in-house testing	4
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus	4
Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan	4
A reverse-transcription droplet digital PCR assay to detect and quantify SARS-CoV-2 RNA in upper respiratory tract specimens	4
Predictors of unfavorable outcome in children hospitalized with influenza and differences in clinical presentation among serotypes	4
Phylodynamics of human metapneumovirus and evidence for a duplication-deletion model in G gene variant evolution	4
A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents	4
Evaluation of a Modified 2-Step Diagnostic Algorithm for Human Immunodeficiency Virus type 1 Utilizing an HIV-1/2 antigen/antibody immunoassay screen and an HIV Nucleic Acid Amplification Test	4
Sierra SARS-CoV-2 sequence and antiviral resistance analysis program	4
Pathogen surveillance of acute conjunctivitis reveals recent emergence of coxsackievirus A24 variants and high genotypic diversity of human adenoviruses in Shenzhen, China, 2018–2024	4
Increasing rhinovirus prevalence in paediatric intensive care patients since the SARS-CoV2 pandemic	3
Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021–2022	3
Increased detection of Echovirus 6-associated meningitis in patients hospitalized during the COVID-19 pandemic, Israel 2021–2022	3
Editorial Board	3
Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow	3
In memoriam David Brown, December 2024	3
Early viral load outperforms cytokines and lymphocytes in predicting SFTS prognosis: A dynamic immune profiling study	3
Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing	3
Performance evaluation of the Aptima CMV quant assay using plasma and non-plasma samples	3
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood	3
Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, rand	3
Editorial Board	3
Editorial Board	3
Syndromic approach for rapid detection and differentiation of human pathogenic alphaviruses	3
Emergence of influenza A(H1N1)pdm09 6B.1A.5a.2a and 6B.1A.5a.2a.1 subclades leading to subtyping failure in a commercial molecular assay	3
Editorial Board	3
Development and characterization of secondary standards for nucleic acid amplification technology (NAAT) assays for detection of hepatitis E virus	3
Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses	3
ESCV/PASCV Membership	3
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory	3
Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar	3
ESCV/PASCV Membership	3
COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response	3
Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodies	3
International external quality assessment study for detection of monkeypox virus by PCR supporting laboratory preparedness during the 2022–2023 mpox outbreak and beyond	3
Development and evaluation of the digital PCR-based method for clinical monitoring of viral loads during severe fever with thrombocytopenia syndrome virus infection	3
Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)	3